profile-img
ECOG-ACRIN Cancer Research Group

@eaonc

Biomarker-driven medical research involving adults who have or are at risk of developing cancer

calendar_today18-11-2013 15:23:53

6,8K Tweets

6,1K Followers

2,2K Following

ECOG-ACRIN Cancer Research Group(@eaonc) 's Twitter Profile Photo
ECOG-ACRIN Cancer Research Group
@eaonc

7 months ago

Trial Activation: EA2222/PUMP, led by Michael Lidsky, MD, FACS of Duke Surgical Oncology and Duke Cancer, is a randomized phase III study of with or without hepatic arterial infusion for unresectable liver metastases. For more info: bit.ly/ea2222-pump

Trial Activation: EA2222/PUMP, led by @michael_lidsky of @DukeSurgOnc and @DukeCancer, is a randomized phase III study of #systemictherapy with or without hepatic arterial infusion for unresectable #colorectal liver metastases. For more info: bit.ly/ea2222-pump #ColonCancer
account_circle